Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature.

Zaid AmmariStella C PakMohammed Ruzieh Osama Dasa Abhinav TiwariJuan C JaumeMaria A Alfonso-Jaume

Published in: Case reports in endocrinology (2018)

Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.

Keyphrases

polycystic kidney disease
type diabetes
wound healing
high glucose
case report
diabetic rats
emergency department
glycemic control
endothelial cells
adipose tissue
metabolic syndrome
insulin resistance
weight loss
stress induced